Please login to the form below
Ranbaxy wins FDA approval for Metformin in US
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
Ipca Laboratories, which has a strategic alliance with Ranbaxy, will manufacture the formulation at its facilities in India. Ranbaxy will commercialise the product in the US market, Ipca revealed in a press statement to the Bombay Stock Exchange.
Total annual US sales for Metformin, an insulin sensitising agent, was USD 379m, according to Ranbaxy.
Share
Related Hub content
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
starting from £32, 500
-
Senior Medical Writer
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Medical Director
-
Excellent benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Market Access Consultant - Cheshire
-
Negotiable
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Freelance Senior Account Manager – healthcare advertising
-
Employment Type:. Healthcare Advertising Jobs. Salary:. 250 to 320 per day
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
Subscribe to our email news alerts
- Novo’s oral diabetes drug hits the mark again
- AZ’s soon-to-be lung cancer blockbuster Tagrisso approved in Japan
- Envision Pharma Group relocates to support growth
- Evoke Group unveils new identity
- Roche’s Alecensa backed by China’s National Drug Administration
- FDA green lights BMS’ Opdivo for ‘hard-to-treat’ small cell lung cancer
PMHub
Grace Communications
Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....
Latest intelligence
- The European Medicines Agency: PRIME’d for access?
- Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
- How can pharma engage with key stakeholders on NHS service transformation?
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
- The race for an HIV ‘cure’
- Supercharging therapies as pharma and patients work together...
Quick links
Infographics
